News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|September 2, 2016

What Are Neuroendocrine Tumors?

Episodes in this series

EP. 1 What Are Neuroendocrine Tumors?

EP. 1 What Are Neuroendocrine Tumors?

EP. 2 Pancreatic NETs: Michael's Story

EP. 2 Pancreatic NETs: Michael's Story

EP. 3 A Surgery Story: Pancreatic NETs

EP. 3 A Surgery Story: Pancreatic NETs

EP. 4 Why You Need an Expert in NETS

EP. 4 Why You Need an Expert in NETS

EP. 5 Living with Carcinoid Tumors

EP. 5 Living with Carcinoid Tumors

EP. 6 Brenda's Carcinoid Tumor Diagnosis

EP. 6 Brenda's Carcinoid Tumor Diagnosis

EP. 7 Why Carcinoid Tumors Might Be Missed

EP. 7 Why Carcinoid Tumors Might Be Missed

EP. 8 What a Carcinoid Cancer Diagnosis Means

EP. 8 What a Carcinoid Cancer Diagnosis Means

EP. 9 NETs: The First Steps to Treatment

EP. 9 NETs: The First Steps to Treatment

EP. 10 About The Carcinoid Cancer Foundation

EP. 10 About The Carcinoid Cancer Foundation

EP. 11 Finding Answers to Your First Questions

EP. 11 Finding Answers to Your First Questions

EP. 12 Reasons for Starting Treatment of NETs

EP. 12 Reasons for Starting Treatment of NETs

EP. 13 Pancreatic NETs: What to Ask Your Oncologist

EP. 13 Pancreatic NETs: What to Ask Your Oncologist

EP. 14 Treating Pancreatic NETs

EP. 14 Treating Pancreatic NETs

EP. 15 Carcinoid Tumors: What to Ask Your Oncologist

EP. 15 Carcinoid Tumors: What to Ask Your Oncologist

EP. 16 Approach to Treating Carcinoid Tumors

EP. 16 Approach to Treating Carcinoid Tumors

EP. 17 Patient Treatment Experiences

EP. 17 Patient Treatment Experiences

EP. 18 NETs: A Personalized Approach

EP. 18 NETs: A Personalized Approach

EP. 19 The Need for Support

EP. 19 The Need for Support

EP. 20 Affording the Best Care

EP. 20 Affording the Best Care

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Most premenopausal women with early breast cancer accepted GnRHa during chemotherapy to preserve ovarian function; cryopreservation uptake was lower: © stock.adobe.com.

Fertility Decisions Influenced by Age and Parental Status in Premenopausal Breast Cancer

December 12th 2025

Inluriyo and Verzenio helped patients with ER+/HER2– advanced breast cancer stay on treatment longer without their disease worsening vs standard therapy.

Inluriyo/Verzenio Extends Treatment Benefit in ER+/HER2– Breast Cancer

ByJason Broderick

December 12th 2025

The FDA approved Akeega combination therapy for adults with BRCA2-mutated metastatic castration-sensitive prostate cancer.

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

BySpencer Feldman

December 12th 2025

image of woman.

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

December 12th 2025

mobile phone

Electronic Intervention Improves Quality of Life in Younger Breast Cancer Survivors

December 12th 2025

Trending on CURE

Single-Drug Approach Explored for Newly Diagnosed Multiple Myeloma

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

What Does Minimal Residual Disease Mean?

From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey

Radiation Plus Keytruda Before Surgery Boosts Immune Response in Breast Cancer

© 2025 MJH Life Sciences^®

All rights reserved.